Chronic Wounds Clinical Trial
— DouReVOfficial title:
Evaluation of the Effect of Virtual Reality on Pain in the Management of Chronic Wounds: Multicentric Randomized Controlled Trial.
Pain management is a priority axis of health insurance spending objectives and contributes to improving the quality of care.There are several types of pain: acute, chronic and induced. These are often found in the management of chronic wounds. The high prevalence of chronic wounds represents a major public health problem. Chronic wounds require long, painful and regular treatment. When dressing these wounds, pain management is essential. Indeed, it can generate healing delays. Usually, pharmacological methods are used to reduce the pain induced by care. But these methods can lead to undesirable effects. Thus, new non-pharmacological techniques are emerging.The investigators therefore wish to assess the effect of virtual reality on pain induced by care during the repair of dressings in the management of chronic wounds.
Status | Not yet recruiting |
Enrollment | 124 |
Est. completion date | May 1, 2022 |
Est. primary completion date | March 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults - Knowing how to read and write French - Able to understand the issues of the study and give consent - Carrier of a chronic wound (ulcers, bedsores or wounds of the diabetic foot) - Requiring a weekly dressing treatment in the department for at least 4 successive treatments(4 weeks) - With pain during pre-inclusion care at least =3 to the Visual Analog Scale - Person with cognitive and sensory capacities adapted to Virtual Reality (pre-inclusion verification on a device test of 5 to 10 minutes) - Person affiliated or beneficiary of a social security scheme Exclusion Criteria: - Carriers of a wound located on the face or end of the head and interfering with the proper use of the Virtual Reality mask - Visually impaired and / or hard of hearing impacting the correct use of the Virtual Reality mask (test of 5 to 10 minutes of the device during the pre-inclusion visit) - Patient not fluent in French. - Current diagnosis of epilepsy, dementia or other neurological diseases preventing the use of Virtual Reality hardware and software - Patients under guardianship or curators |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier Universitaire de Limoges | Limoges | |
France | Centre Hospitalier Universitaire de la Réunion | Saint-Pierre |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de la Réunion |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Treatment-induced pain | (AVS) Analog Visual Scale 0 to 10 : 0 for no pain ; 10 for maximum pain imaginable | 4 weeks | |
Secondary | Level of situational anxiety | (STAI-Y-A) State-Trait Anxiety Scale - Overall score varies between 20 and 80. The higher the score, the more anxious the patient. | 4 weeks | |
Secondary | Duration of treatment | time in seconds | 4 weeks | |
Secondary | Worse Treatment-induced pain | Analog Visual Scale | 4 weeks | |
Secondary | Frequency of use of analgesic | analgesic consumption | 4 weeks | |
Secondary | Time spent thinking about pain | (AVS) Analog Visual Scale 0 to 10 : 0 for no thought of pain ; 10 for throughout the treatment | 4 weeks | |
Secondary | Healing process | measurement of the wound on photograhies by imageJ ® planimetry software | 4 weeks | |
Secondary | Medical Outcome Study Short Form | (SF6) Short Form (36) Health Survey_ Quality of life questionnaire | 4 weeks | |
Secondary | Tolerance of virtual reality | frequency of occurrence and intensity of motion sickness events | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01442103 -
Clinical Utility of a New Silver Gel for Use on Chronic Wounds
|
N/A | |
Completed |
NCT00425178 -
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
|
Phase 1 | |
Recruiting |
NCT03882983 -
Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound
|
Phase 1 | |
Completed |
NCT04903366 -
Absorption and Safety of Topical Timolol to Treat Chronic Wounds
|
||
Not yet recruiting |
NCT05491291 -
Chronic Wound Care of Lower Limb in M@diCICAT Center at CHU de Martinique
|
N/A | |
Completed |
NCT01572376 -
Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment
|
Phase 1/Phase 2 | |
Recruiting |
NCT06306716 -
Single Center Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds
|
||
Completed |
NCT02053337 -
A RCT to Compare Performance of Two Foam Dressings on Patient Well-being Related Endpoints.
|
N/A | |
Completed |
NCT02519166 -
Characterisation of Biofilm of the Chronic Wounds
|
N/A | |
Completed |
NCT04320628 -
Randomized Double-Blind Controlled Clinical Trial
|
N/A | |
Completed |
NCT04342767 -
The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds
|
||
Not yet recruiting |
NCT05493943 -
P.E.M.F. Therapy of Chronic Wounds
|
N/A | |
Completed |
NCT01881815 -
Swab Sample Collection for the Detection of Bacterial Proteases
|
N/A | |
Not yet recruiting |
NCT06424561 -
The Influence of Systematic Psychological Intervention on Patients About VSD Drainage Surgery
|
N/A | |
Completed |
NCT05764226 -
Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds
|
N/A | |
Completed |
NCT03678636 -
WOUNDCHEK Bacterial Status Benefits Evaluation
|
N/A | |
Terminated |
NCT03198169 -
A Study to Investigate Two Atteris Antimicrobial Products on Chronic Wound Healing.
|
N/A | |
Withdrawn |
NCT04172363 -
Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics
|
Phase 3 | |
Not yet recruiting |
NCT05187676 -
Clinical Evaluation of an Innovative Non-contact Optical Device for Skin Oxygenation Imaging
|
N/A | |
Recruiting |
NCT00535548 -
Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model
|
Phase 1 |